Kevin Punie

Jun 5, 2024 | nature.com | Hope Rugo |Kevin Punie |Aditya Bardia |Sara A. Hurvitz |Javier Cortés |Véronique Diéras | +2 more

Correction to: npj Breast Cancer (2022) 8:98; https://doi.org/10.1038/s41523-022-00467-1, published online 29 August 2022The article includes two typographical errors, on pages 5 and 6. On page 5, in the sentence beginning with “Dose interruptions…”, and on page 6, in the sentence beginning with “A higher frequency…”, the order of the percentage of patients in the SG and TPC arms who discontinued treatment due to adverse events in the ASCENT trial has been written backwards.

Feb 29, 2024 | ascopubs.org | Hope Rugo |Sara M. Tolaney |Kevin Punie

Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned co-primary or secondary analyses are not yet available. Clinical Trial Updates provide an opportunity to disseminate additional results from studies, published in JCO or elsewhere, for which the primary end point has already been reported.